Patent · US Expired

Chemical compounds

US7348341B2 · kind B2 · utility

3Cited by
7References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 30, 2001
Grant dateMar 25, 2008
Priority date—
Expiry dateOct 19, 2021

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention concerns compounds of formula (I), and their use in therapy, particularly in the modulation of CCR3 activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.